Details for New Drug Application (NDA): 076204
✉ Email this page to a colleague
NDA 076204 describes MOEXIPRIL HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Chartwell Rx, Glenmark Pharms Ltd, Teva, Glenmark Pharms, and Heritage, and is included in eight NDAs. It is available from two suppliers. Additional details are available on the MOEXIPRIL HYDROCHLORIDE profile page.
The generic ingredient in MOEXIPRIL HYDROCHLORIDE is hydrochlorothiazide; moexipril hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.
The generic ingredient in MOEXIPRIL HYDROCHLORIDE is hydrochlorothiazide; moexipril hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.
Summary for 076204
| Tradename: | MOEXIPRIL HYDROCHLORIDE |
| Applicant: | Teva |
| Ingredient: | moexipril hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 076204
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
Suppliers and Packaging for NDA: 076204
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| MOEXIPRIL HYDROCHLORIDE | moexipril hydrochloride | TABLET;ORAL | 076204 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-0017 | 0093-0017-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-0017-01) |
| MOEXIPRIL HYDROCHLORIDE | moexipril hydrochloride | TABLET;ORAL | 076204 | ANDA | Teva Pharmaceuticals USA, Inc. | 0093-5150 | 0093-5150-01 | 100 TABLET, FILM COATED in 1 BOTTLE (0093-5150-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 7.5MG | ||||
| Approval Date: | May 8, 2003 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 15MG | ||||
| Approval Date: | May 8, 2003 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
